Marijuana is already legal in many states, and a growing number of GOP Congressmen are ready to make it the law of the land — but there's a debate over revenue.

Representatives of Georgia’s nascent medical marijuana industry are expressing frustration with the state’s process for issuing licenses to grow and process cannabis into a therapeutic oil used by registered patients for conditions including seizures and intractable pain.

In Washington, adults can now walk away from their COVID-19 vaccine appointment with a free, pre-rolled joint. Other states are also offering incentives to try to convince people to get the shot.

Until recently, plants from only one U.S. facility were approved for use in research. Adding new suppliers will accelerate understanding of cannabis' health effects and possible therapeutic uses.

Medical marijuana is nearing reality for thousands of Georgians suffering from serious health conditions as state officials sift through applications for growing licenses and lawmakers recently paved the way for pharmacies to become dispensaries.

Growers likely took advantage of less-populated streets due to the coronavirus pandemic, police say. But the reduction in city traffic also made the cannabis plants' pungent odor more noticeable.

The vote follows World Health Organization guidance saying that due to cannabis' therapeutic use and other factors, it "is not consistent with the criteria" for a Schedule IV drug.

While a THC seltzer may seem like a niche product, it's actually part of a larger pattern, as big companies try to learn more about a part of the cannabis market that could see explosive growth.

The race for governor of Georgia has turned into a sprint now that the 2018 general assembly has concluded its business. What ammunition did the session...